Ginsenoside Rg1 alleviates Aβ deposition by inhibiting NADPH oxidase 2 activation in APP/PS1 mice

BACKGROUND: Ginsenoside Rg1 (Rg1), an active ingredient in ginseng, may be a potential agent for the treatment of Alzheimer’s disease (AD). However, the protective effect of Rg1 on neurodegeneration in AD and its mechanism of action are still incompletely understood. METHODS: Wild type (WT) and APP/...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Han, Su, Yong, Sun, Zhenghao, Chen, Ming, Han, Yuli, Li, Yan, Dong, Xianan, Ding, Shixin, Fang, Zhirui, Li, Weiping, Li, Weizu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569324/
https://www.ncbi.nlm.nih.gov/pubmed/34764721
http://dx.doi.org/10.1016/j.jgr.2021.03.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569324/
https://www.ncbi.nlm.nih.gov/pubmed/34764721
http://dx.doi.org/10.1016/j.jgr.2021.03.003

Ejemplares similares